Suppr超能文献

非酒精性脂肪性肝病与肾脏:综述

Nonalcoholic Fatty Liver Disease and the Kidney: A Review.

作者信息

Umbro Ilaria, Baratta Francesco, Angelico Francesco, Del Ben Maria

机构信息

Geramed Dialysis Center, Fiano Romano, 00065 Rome, Italy.

Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy.

出版信息

Biomedicines. 2021 Oct 1;9(10):1370. doi: 10.3390/biomedicines9101370.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is associated with several extrahepatic manifestations such as cardiovascular disease and sleep apnea. Furthermore, NAFLD is reported to be associated with an increased risk of incident chronic kidney disease (CKD). Inflammation and oxidative stress are suggested to be the key factors involved in the inflammatory mechanisms and pathways linking NAFLD to CKD and are responsible for both the pathogenesis and the progression of CKD in NAFLD patients. This review aims to provide a more comprehensive overview of the association between CKD and NAFLD, also considering the effect of increasing severity of NAFLD. A PubMed search was conducted using the terms "non-alcoholic fatty liver disease AND kidney". In total, 537 articles were retrieved in the last five years and 12 articles were included in the qualitative analysis. Our results showed that CKD developed more frequently in NAFLD patients compared to those without NAFLD. This association persisted after adjustment for traditional risk factors and according to the severity of NAFLD. Therefore, patients with NAFLD should be considered at high risk of CKD. Intensive multidisciplinary surveillance over time is needed, where hepatologists and nephrologists must act together for better and earlier treatment of NAFLD patients.

摘要

非酒精性脂肪性肝病(NAFLD)与多种肝外表现相关,如心血管疾病和睡眠呼吸暂停。此外,据报道,NAFLD与慢性肾脏病(CKD)发病风险增加有关。炎症和氧化应激被认为是将NAFLD与CKD联系起来的炎症机制和途径中的关键因素,并且是NAFLD患者CKD发病机制和进展的原因。本综述旨在更全面地概述CKD与NAFLD之间的关联,同时考虑NAFLD严重程度增加的影响。使用“非酒精性脂肪性肝病与肾脏”这一检索词在PubMed上进行了搜索。过去五年共检索到537篇文章,其中12篇纳入定性分析。我们的结果显示,与无NAFLD的患者相比,NAFLD患者中CKD的发生更为频繁。在对传统危险因素进行校正后以及根据NAFLD的严重程度,这种关联仍然存在。因此,应将NAFLD患者视为CKD的高危人群。随着时间的推移,需要进行强化的多学科监测,肝病学家和肾病学家必须共同行动,以便更好、更早地治疗NAFLD患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e2/8533178/65670a6060dd/biomedicines-09-01370-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验